⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
FHTX News
Foghorn Therapeutics Inc. Common Stock
Foghorn Therapeutics Provides Third Quarter 2025 Financial and Corporate Update
globenewswire.com
FHTX
Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences
globenewswire.com
FHTX
Foghorn Therapeutics Announces Updates for Selective ARID1B, Selective CBP and Selective EP300 Degrader Programs
globenewswire.com
FHTX
Foghorn Therapeutics Announces Significant Progress for Selective ARID1B Degrader at the 8th Annual TPD and Induced Proximity Summit
globenewswire.com
FHTX